U.S. Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers
4Front Ventures Corp (FFNTF) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Retail Challenges
4Front Ventures Corp (FFNTF) reports strong wholesale performance and strategic expansions, despite facing retail market pressures and revenue declines. Nov 15, 2024
GuruFocus News Drug Manufacturers
Lowell Farms Inc (LOWLF) Q3 2024 Earnings Call Highlights: Strategic Retail Expansion Amid Revenue Challenges
Despite a significant revenue decline, Lowell Farms Inc (LOWLF) focuses on strategic retail growth and cost-saving measures to enhance future profitability. Nov 15, 2024
GuruFocus News Drug Manufacturers
CV Sciences Inc (CVSI) Q3 2024 Earnings Call Highlights: Strategic Acquisitions and New Product Launches Amid Revenue Challenges
CV Sciences Inc (CVSI) reports a slight revenue decline but maintains strong gross margins and expands product offerings to navigate market challenges. Nov 15, 2024